Advertisement
Home Tags Cancer: Rectal

Tag: Cancer: Rectal

A minority of colorectal cancer survivors experience social distress

Social Distress ID’d in Minority of Colorectal Cancer Survivors

0
Strongest predictor of social distress is having three or more long-term conditions
Regularly taking low-dose aspirin or other nonsteroidal anti-inflammatory drugs may lower long-term risk of colorectal cancer

Low-Dose Aspirin, Other NSAIDs May Lower Colorectal Cancer Risk

0
Findings for consistent use over 5 or more years
A scoring system can stratify risk for advanced colorectal neoplasia in asymptomatic adults

Index Stratifies Risk for Advanced Colorectal Neoplasia

0
Authors suggest scoring system may allow tailoring of screening methods in those at average risk
More than a third of colorectal cancers diagnosed in younger patients are caused by inherited gene mutations

35% of Colorectal Cancers in Patients Age ≤35 Are Genetic

0
Study authors recommend that people diagnosed before age 35 get tested
People living in 94 counties spread across the lower Mississippi Delta region

Pockets of U.S. Have Excessive Colorectal Cancer Mortality

0
Areas include parts of the Mississippi Delta, Appalachia, and eastern Virginia
Higher-quality colonoscopies are associated with a 50 to 60 percent lower risk for colorectal cancer and colorectal cancer fatalities over a patient's lifetime

Net Savings for Higher-Quality Colonoscopy

0
Those with higher polyp detection rates prevent more cancers, save more lives
The Affordable Care Act may have helped boost rates of colorectal cancer screening among lower income Americans

Rise in CRC Screening Rates After ACA Implementation

0
Increase in colonoscopy, other tests typically seen among poorer, less educated Americans
Incorporation of a genetic risk score can improve the accuracy of colorectal cancer risk determination

Model Including CRC Risk Alleles Ups Risk Discrimination

0
Model more accurately determines risk of colorectal cancer; defines recommended screening age
Population-based fecal immunochemical testing screening in adults aged 50 to 69 years can reduce colorectal cancer mortality

Population-Based FIT Screening Can Reduce CRC Mortality

0
Large cohort study shows significant reduction among screened 50- to 69-year-olds in Taiwan
For patients with refractory metastatic colorectal cancer

TAS-102 Ups Overall Survival in Refractory Metastatic CRC

0
Most frequently observed clinically significant adverse events include neutropenia, leukopenia